Minhui Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Minhui Xu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Ji Zhou
Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China
2 shared publicationsLiang Yi
Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China
2 shared publicationsLunshan Xu
Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China
2 shared publicationsQing Ouyang
Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China
2 shared publicationsHong Liang
Third Military Medical University
1 shared publicationHongjie Chen
Fuzhou General Hospital of Xiamen University
1 shared publication
Latest Publications
- 1 December 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (12) , 2896-2902
Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway
- 1 December 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (12) , 2896-2902
Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway
- 15 June 2014
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 16 (3) , 578-586
HIF-1α Genetic Variants and Protein Expression Confer the Susceptibility and Prognosis of Gliomas
To investigate the role of HIF-1α genetic polymorphism of c.1772C>T and c.1790G>A in the incidence and prognosis of gliomas in a Chinese cohort, a total of 387 gliomas patients and 437 age- and sex-matched healthy controls were recruited. The genetic polymorphism of c.1772C>T and c.1790G>A was determined. We found that the genotype distribution at c.1772C>T showed significant difference between patients and controls. Multivariable analyses showed a significantly higher risk for gliomas in 1772TT genotype carriers (odds ratio 2.68, with CC as reference). In addition, we also found a significantly higher risk for grade III + IV gliomas was observed in 1772TT genotype carriers (odds ratio 2.21, with CC as reference). The overall survival rates in patients with 1772TT or 1772CT genotype were markedly lower compared with patients with CC (both P < 0.01). Our in vitro studies revealed that HIF-1α regulates the proliferation, migration and invasion of human glioma U251 cells. This study suggests that the c.1772C>T polymorphisms may be used as a molecular marker for gliomas occurrence, grades and clinical outcome in gliomas patients.
- 15 June 2014
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 16 (3) , 578-586
HIF-1α Genetic Variants and Protein Expression Confer the Susceptibility and Prognosis of Gliomas
To investigate the role of HIF-1α genetic polymorphism of c.1772C>T and c.1790G>A in the incidence and prognosis of gliomas in a Chinese cohort, a total of 387 gliomas patients and 437 age- and sex-matched healthy controls were recruited. The genetic polymorphism of c.1772C>T and c.1790G>A was determined. We found that the genotype distribution at c.1772C>T showed significant difference between patients and controls. Multivariable analyses showed a significantly higher risk for gliomas in 1772TT genotype carriers (odds ratio 2.68, with CC as reference). In addition, we also found a significantly higher risk for grade III + IV gliomas was observed in 1772TT genotype carriers (odds ratio 2.21, with CC as reference). The overall survival rates in patients with 1772TT or 1772CT genotype were markedly lower compared with patients with CC (both P < 0.01). Our in vitro studies revealed that HIF-1α regulates the proliferation, migration and invasion of human glioma U251 cells. This study suggests that the c.1772C>T polymorphisms may be used as a molecular marker for gliomas occurrence, grades and clinical outcome in gliomas patients.